One year ago, Congress defunded public media. Now that we're 100% community funded, please become a sustaining member or increase your existing membership today.
LA Sues Company In Beverly Hills For Selling An Unapproved Coronavirus Test
This scanning electron microscope image shows SARS-CoV-2 (round gold objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. (NIAID-RML)
Los Angeles prosecutors are suing a company with offices in Beverly Hills for selling an at-home COVID-19 blood test that has not been approved by the Food and Drug Administration.
The L.A. City Attorney and L.A. County District Attorney announced the suit against the Applied BioSciences Corporation, its president, Chris Bridges, and founder Scott Stevens. The company claims it is "focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases," according to a statement from the city and county.
District Attorney Jackie Lacey says that fraudulent medical tests are a public health risk because they can give consumers a false sense of security that they aren't sick.
"People who believe they are healthy or virus-free are more likely to return to work and otherwise move about freely, increasing the risk to themselves and others."
Prosecutors say the company claimed in advertisements its tests could diagnose COVID-19 from a single finger prick of blood — and could do it with 96.3% accuracy in 15 minutes. The company allegedly marketed and sold the test kits on its website for $35 each.
The lawsuit aims to stop the company from marketing or selling the kits and seeks restitution for consumers who bought them.
Last month, city attorney Mike Feuer announced similar actions taken against businesses selling unapproved at-home kits. This lawsuit is the latest in a crackdown on coronavirus-related fraud with officials targetting companies for price gouging and making false and misleading claims.
Sponsored message
Our news is free on LAist. To make sure you get our coverage: Sign up for our daily coronavirus newsletter. To support our non-profit public service journalism: Donate Now.
One year ago, Congress voted to defund public media, eliminating a critical $1.7 million from our budget every year going forward. But they couldn’t silence us, and we’re not going anywhere. LAist is now 100% community funded and that means we’re taking our future into our own hands and turning to you to keep local reporting strong.
You come to LAist because you want independent reporting and trustworthy local information. Our nonprofit newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our communities. We are free to follow facts wherever they lead and to hold power to account without fear or favor. Our only loyalty is to our readers and listeners and our mission: to inform, engage, and strengthen Southern California’s communities.
If this story helped you, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
You come to LAist because you want independent reporting and trustworthy local information. Our nonprofit newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our communities. We are free to follow facts wherever they lead and to hold power to account without fear or favor. Our only loyalty is to our readers and listeners and our mission: to inform, engage, and strengthen Southern California’s communities.
If this story helped you, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
Senior Vice President News, Editor in Chief
